Breast, The Value of Protons, Cardiotoxicity and RadComp
During ISOP 2022, Shannon McDonald presented "Breast, The Value of Protons, Cardiotoxicity and RadComp".
Watch the webinar above.
During ISOP 2022, Shannon McDonald presented "Breast, The Value of Protons, Cardiotoxicity and RadComp".
Watch the webinar above.
The Proton Therapy Centre in Prague (PTC) is a leading global health care facility and one of the most advanced proton therapy providers in Europe. The centre...
This study reports 3-year outcomes of the Proton Collaborative Group phase II trial (PCG BRE007-12) that recruited women ≥ 50 years with node-negative, estrogen...
This study reported early toxicity and cosmetic outcomes of 21 patients treated with breast-conserving surgery and adjuvant PBT. Grade 2 and 3 dermatitis...
Minesh Mehta covers three indications that are very promising for proton therapy: leptomeningeal disease, low-grade glioma, and glioblastoma. Watch the talk's...
Shannon MacDonald covers one of proton therapy's growing indications: breast cancer. In her talk, she focuses on locally advanced breast cancer and cardiac...
Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...
This study compared acute toxicities and reconstructive complications in patients treated with proton-based (n = 11)and photon-based PMRT (n = 26). Grade 2 skin...
A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...